Abstract

The survival and hazard functions are key concepts in survival analysis for describing the distribution of event times. The survival function gives, for every time, the probability of surviving (or not experiencing the event). The hazard function gives the potential that the event will occur, per time unit, given that an individual has survived up to the specified time. While these are often of direct interest, many other quantities of interest (e.g., median survival) may subsequently be estimated from knowing either the hazard or survival function. This research was a five-year retrospective study on data from a record of colorectal cancer patients that received treatments from 2013 to 2017 in Radiotherapy Department of Usmanu Danfodiyo University Teaching Hospital, Sokoto, being it one of the cancer registries in Nigeria. 9 covariates were selected to fit colorectal cancer data using Cox and Weibull Regression Models. From the result it is concluded that the predictor variables could significantly predict the survival of colorectal cancer patients using Cox. Also the result of the Weibull Proportional Hazard Model shows that the model is adequate enough to predict the survival of the colorectal patients. The A. I. C result shows that, according to our colorectal cancer data, the semi-parametric Cox regression model performed better than the parametric Weibull proportional hazards model. However, in the present study, the Cox model provided an efficient and a better fit to the study data than Weibull model.

Highlights

  • Colorectal cancer (CRC) is a tumour of the colon and rectum

  • We can assume the proportional hazards

  • Systematic departures from a horizontal line plot, with the dashed lines representing a standard-error band are indicative of non-proportional hazards, since proportional hazards assumes that estimates, ... , L do not vary much over time

Read more

Summary

Introduction

Colorectal cancer (CRC) is a tumour of the colon and rectum. Most cases of CRC are sporadic; meaning there are no known hereditary (genetic) components, and it develops slowly over several years through adenomatous polyps Blood in the stool, and anaemia are cardinal symptoms and sings of CRC. Fatigue, anorexia, weight loss, pain, jaundice, and other signs and symptoms of locally advanced and metastatic disease occur. CRC is traditionally diagnosed by sigmoidoscopy and colonoscopy using biopsy. There are several ways to treat colorectal cancer depending on the cancer stage and where the tumour is localized. The main treatment is surgery; chemotherapy and radiation therapy can use (Potter & Hunter, [2])

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call